(Q44048968)

29 November 2017

The involvement of 5-HT3 and 5-HT4 receptors in two models of gastrointestinal transit in mice (English)

1 reference

29 November 2017

1 reference

ChEBI release 2020-05-28

3

1 reference

29 November 2017

Pascual D

1

1 reference

29 November 2017

Alsasua A

series ordinal

2

1 reference

29 November 2017

Martín MI

series ordinal

4

1 reference

29 November 2017

language of work or name

English

0 references

publication date

1 July 2002

1 reference

29 November 2017

1 reference

29 November 2017

326

1 reference

29 November 2017

3

1 reference

29 November 2017

163-166

1 reference

5-HTP induced diarrhea as a carcinoid syndrome model in mice?

29 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900251-3

7 January 2021

Short-circuit current responses to 5-hydroxytryptamine in human ileal mucosa are mediated by a 5-HT4 receptor.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900251-3

7 January 2021

The irritable bowel syndrome: mechanisms and a practical approach to management

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900251-3

7 January 2021

A randomized controlled clinical trial of the serotonin type 3 receptor antagonist alosetron in women with diarrhea-predominant irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900251-3

7 January 2021

A new method for measuring auricular inflammation in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900251-3

7 January 2021

Role of opioid ligands in the irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900251-3

7 January 2021

Effect of a 5HT3-antagonist (ondansetron) on rectal sensitivity and compliance in health and the irritable bowel syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900251-3

7 January 2021

RS 39604: a potent, selective and orally active 5‐HT4 receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900251-3

7 January 2021

The 5HT3 antagonist GR38032F is highly toxic in DBA/2 mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900251-3

7 January 2021

Croton oil pleurisy induces pulmonary hyperreactivity

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900251-3

7 January 2021

5-HT3 receptor antagonists. 3. Quinoline derivatives which may be effective in the therapy of irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900251-3

7 January 2021

The central and peripheral influences of opioids on gastrointestinal propulsion

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900251-3

7 January 2021

Croton oil-induced hemorrhoid model in rat: comparison of anti-inflammatory activity of diflucortolone valerate with other glucocorticoids

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900251-3

7 January 2021

Convenient method for assay in vivo of antimetabolites of serotonin

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900251-3

7 January 2021

Effects of ondansetron on gastrointestinal symptoms in carcinoid syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900251-3

7 January 2021

10.1016/S0304-3940(02)00251-3

Identifiers

DOI

1 reference

29 November 2017

1 reference